Wellgistics Health Inc. (NASDAQ: WGRX) completed a 1-for-50 reverse stock split of its common shares, reducing outstanding shares from approximately 125.7 million to approximately 2.5 million shares.

The reverse split took effect at 12:01 a.m. Eastern Time on May 26, 2026, following stockholder approval on April 2, 2026. The company's common stock now trades under a new CUSIP number on the Nasdaq Capital Market.

Under the reverse split structure, every 50 previous shares automatically converted into one share of common stock. The company rounded up any fractional shares to the nearest whole share rather than issuing fractional shares.

The Tampa-based health technology company stated the reverse split aims to increase its per-share trading price to regain compliance with Nasdaq's minimum bid price requirement for continued listing on the Nasdaq Capital Market.

Wellgistics operates a pharmacy dispensing artificial intelligence platform called EinsteinRx integrated with its blockchain-enabled smart contracts platform PharmacyChain. The company's platform connects more than 6,500 pharmacies and 200 manufacturers, according to the press release.